Posted on February 19, 2016

International guest speakers from 15 countries will combine with local experts to present a series of lectures, case studies, presentations and workshops as part of Hamad Medical Corporation’s (HMC) First Annual Qatar Neuroscience Conference, to be held this weekend in Doha. The three-day conference, which runs from 18th – 20th February at the Sheraton Hotel, is the first of its kind to be held by HMC, with speakers focusing their talks on stroke, epilepsy, and brain tumors respectively across each of the three days of the symposium.

Around 500 participants are expected to attend the conference, which is being organized by the Neuroscience Institute as part of the Academic Health System (AHS) program office. The sessions will be divided into general assemblies during the morning of each day, and led by a different specialty, with parallel tracks for the afternoon sessions providing a more in-depth investigation for delegates in their particular area of neuro- expertise, as well as targeted nurse therapy workshops. Chairman of the Radiography Scientific Committee and HMC’s Senior Consultant, Dr. Ahmed Own, said that the conference allows for collaboration between international and local experts, providing a fertile learning environment for neuroscientists working in Qatar.

“We are thrilled to be able to provide our clinicians the chance to collaborate and learn from leading experts in the fields of neuro-radiology, neurology and neurosurgery, which is a first for HMC,” said Dr. Own. Previously, each of the neuro- specialties held separate events, but the establishment of the Neurosciences Institute has helped to facilitate a combined conference platform, added Dr. Own. “A joint neuroscience conference makes sense from a collaborative point of view, and also makes sense from an economic point of view, and we are expecting to receive over 550 delegates for this event,” continued Dr. Own.

HMC Chairman of Neuro-surgery, Dr. Ghanim Al Sulaiti said the conference themes confront some of the most important challenges faced by neuroscientists in Qatar. “Stroke is the second leading cause of death globally and the incidence of stroke in Qatar is extremely worrying, with strokes occurring in patients on average almost 20 years younger than in the US or the UK, said Dr. Al Sulaiti. “Similarly, Qatar has the highest incidence of brain cancer in the GCC region, and it is estimated that between three to four percent of the population in Qatar have epilepsy, so this conference will stimulate debate among the local neuroscientific community about these illnesses and how to combat them,” added Al Sulaiti.

The conference is supported by main sponsors, Sedeer Medical Services and Amico, and gold sponsor, Al Tafaoal.

For more information, and to register, visit www.hamad.qa events and conference section. 

Categories: